Kidney Disease as a Clinical Predictor in the Prognosis of Patients with Covid-19
Solange Deianira Azpitarte1*, Oscar Emmanuel Grimaldo2
12° Hospitalization Operational Unit of the 8th Armored Regime, 2nd Level of Medical Care, SEDENA, Irapuato, México
2University of Celaya, Medicine School, Rancho Pinto, Celaya, México
*Corresponding Author: Dr. Solange Deianira Azpitarte, 2° Hospitalization Operational Unit of the 8th Armored Regime, 2nd Level of Medical Care, SEDENA, Irapuato, México
Received: 01 October 2020; Accepted: 08 October 2020; Published: 10 October 2020
Citation: Solange Deianira Azpitarte, Oscar Emmanuel Grimaldo. Kidney Disease as a Clinical Predictor in the Prognosis of Patients with Covid-19. Archives of Nephrology and Urology 3 (2020): 104-105.View / Download Pdf Share at Facebook
COVID-19; Upper respiratory tract diseases; SARS-CoV-2; ACE2 enzyme
COVID-19 articles; Upper respiratory tract diseases articles; SARS-CoV-2 articles; ACE2 enzyme articles
COVID-19 articles COVID-19 Research articles COVID-19 review articles COVID-19 PubMed articles COVID-19 PubMed Central articles COVID-19 2023 articles COVID-19 2024 articles COVID-19 Scopus articles COVID-19 impact factor journals COVID-19 Scopus journals COVID-19 PubMed journals COVID-19 medical journals COVID-19 free journals COVID-19 best journals COVID-19 top journals COVID-19 free medical journals COVID-19 famous journals COVID-19 Google Scholar indexed journals Upper respiratory tract diseases articles Upper respiratory tract diseases Research articles Upper respiratory tract diseases review articles Upper respiratory tract diseases PubMed articles Upper respiratory tract diseases PubMed Central articles Upper respiratory tract diseases 2023 articles Upper respiratory tract diseases 2024 articles Upper respiratory tract diseases Scopus articles Upper respiratory tract diseases impact factor journals Upper respiratory tract diseases Scopus journals Upper respiratory tract diseases PubMed journals Upper respiratory tract diseases medical journals Upper respiratory tract diseases free journals Upper respiratory tract diseases best journals Upper respiratory tract diseases top journals Upper respiratory tract diseases free medical journals Upper respiratory tract diseases famous journals Upper respiratory tract diseases Google Scholar indexed journals SARS-CoV-2 articles SARS-CoV-2 Research articles SARS-CoV-2 review articles SARS-CoV-2 PubMed articles SARS-CoV-2 PubMed Central articles SARS-CoV-2 2023 articles SARS-CoV-2 2024 articles SARS-CoV-2 Scopus articles SARS-CoV-2 impact factor journals SARS-CoV-2 Scopus journals SARS-CoV-2 PubMed journals SARS-CoV-2 medical journals SARS-CoV-2 free journals SARS-CoV-2 best journals SARS-CoV-2 top journals SARS-CoV-2 free medical journals SARS-CoV-2 famous journals SARS-CoV-2 Google Scholar indexed journals ACE2 enzyme articles ACE2 enzyme Research articles ACE2 enzyme review articles ACE2 enzyme PubMed articles ACE2 enzyme PubMed Central articles ACE2 enzyme 2023 articles ACE2 enzyme 2024 articles ACE2 enzyme Scopus articles ACE2 enzyme impact factor journals ACE2 enzyme Scopus journals ACE2 enzyme PubMed journals ACE2 enzyme medical journals ACE2 enzyme free journals ACE2 enzyme best journals ACE2 enzyme top journals ACE2 enzyme free medical journals ACE2 enzyme famous journals ACE2 enzyme Google Scholar indexed journals kidney articles kidney Research articles kidney review articles kidney PubMed articles kidney PubMed Central articles kidney 2023 articles kidney 2024 articles kidney Scopus articles kidney impact factor journals kidney Scopus journals kidney PubMed journals kidney medical journals kidney free journals kidney best journals kidney top journals kidney free medical journals kidney famous journals kidney Google Scholar indexed journals eletrolyte articles eletrolyte Research articles eletrolyte review articles eletrolyte PubMed articles eletrolyte PubMed Central articles eletrolyte 2023 articles eletrolyte 2024 articles eletrolyte Scopus articles eletrolyte impact factor journals eletrolyte Scopus journals eletrolyte PubMed journals eletrolyte medical journals eletrolyte free journals eletrolyte best journals eletrolyte top journals eletrolyte free medical journals eletrolyte famous journals eletrolyte Google Scholar indexed journals renal tubular cell articles renal tubular cell Research articles renal tubular cell review articles renal tubular cell PubMed articles renal tubular cell PubMed Central articles renal tubular cell 2023 articles renal tubular cell 2024 articles renal tubular cell Scopus articles renal tubular cell impact factor journals renal tubular cell Scopus journals renal tubular cell PubMed journals renal tubular cell medical journals renal tubular cell free journals renal tubular cell best journals renal tubular cell top journals renal tubular cell free medical journals renal tubular cell famous journals renal tubular cell Google Scholar indexed journals
Letter to the Editor
We are living an unprecedented situación in the history of medicine, which is being produced by the COVID-19 pandemic and which has modified the situation of health systems worldwide. This situation will modify the way in which we will face respiratory diseases and in particular the way in which we will assess patients with these pathologies [1, 2].
Our country faces other great difficulties such as the enormous number of people susceptible to the disease and the scarce allocation of resources to their care by the health sector. Early detection is limited, as the signs and symptoms are similar to those of other upper respiratory tract diseases. For this reason, the recent Covid-19 disease has brought with it a real challenge both in health and in the basic aspects of daily life. Without doubt, it has become a struggle for the medical sector.
Much is still unknown about SARS-CoV-2, but early research supports the hypothesis that the severity of COVID-19 is conditioned by the hyper-inflammatory response that occurs in our body when in contact with SARS-CoV-2. The severity of the condition is related to the respiratory failure it causes, however, there are studies that do not limit pulmonary involvement. Research indicates that the access mechanism of SARS-CoV-2 to the body is closely related to the ACE2 enzyme. Enzyme that among other tissues, can be found in the epithelium of renal tubular cells. This is the reason why there are data from patients with COVID-19 who have a great effect on kidney function and can present with Acute Renal Insufficiency (a poor prognostic factor) .
There are already studies in different parts of the world where it is being observed that kidney function is altered upon admission of patients with covid-19 and they are more likely to be admitted to an intensive care unit and need mechanical ventilation. Higher incidence of Acute Kidney Injury in these patients [4, 5].
This is a serious problem in our country of Mexico since it has been estimated that, at present, around 6.2 million Mexicans with diabetes have kidney failure in its different stages, without necessarily all of them knowing that they suffer from it. Up to 98% of people with chronic kidney disease due to diabetes in Mexico are in the early stages, when fortunately chronic kidney disease is still controllable and reversible .
It seems clear that cells with expression of ACE2 can act as target cells for the virus, and among these are tubular epithelial cells. For this reason, it appears that the kidney could be a target organ for the virus, which may cause Acute Kidney Injury in the most serious cases and with the worst prognosis .
In conclusion, due to the magnitude of the pandemic, it will be vitally important to pay attention to the admission values of patients hospitalized for COVID-19 such as creatinine, renal function rate, and serum electrolytes, since they will be useful for risk stratification to predict kidney injury acute and be a clinical predictor in its evolution.
- Tobin MJ, Laghi F, Jubran A. Why COVID-19 Silent Hypoxemia is Baffling to Physicians. Am J Respir Crit Care 202 (2020): 356-360.
- Jounieaux V, Parreira VF, Aubert G, et al. Effects of hypocapnic hyperventilation on the response to hypoxia in normal subjects receiving intermittent positive-pressure ventilation. Chest 121 (2002): 1141-1148.
- Zou X, Chen K, Zou J, et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med (2020).
- Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382 (2020): 1708-1720.
- Chan L, Chaudhary K, Sana A, et al. AKIN in Hospitalized Patients with COVID-19. JASN (2020): ASN.2020050615.
- Figueroa-Lara A, Gonzalez-Block MA, Alarcon-Irigoyen J. Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers. PloS one 11 (2016): e0145177.
- Hidalgo-Blanco MA, Andreu-Periz D, Moreno-Arroyo MC. COVID-19 in kidney patients. Brief review. Ill Nefrol 23 (20120): 122-131.